AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.
Cancer Discov
; 4(9): 1046-61, 2014 Sep.
Article
in En
| MEDLINE
| ID: mdl-24893891
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Acrylamides
/
Drug Resistance, Neoplasm
/
Protein Kinase Inhibitors
/
ErbB Receptors
/
Aniline Compounds
/
Lung Neoplasms
/
Mutation
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Discov
Year:
2014
Document type:
Article
Country of publication:
Estados Unidos